Notice of Flow Capital's Second Quarter 2018 Financial Results Conference Call
TORONTO, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) ("Flow Capital" and "Flow") today announced it will release its second quarter 2018 financial results after the markets close on Thursday, August 23, 2018. Mr. Robb McLarty, Acting Chief Executive Officer, and Mr. Donnacha Rahill, Chief Financial Officer, will host a conference call at 8:00 a.m. ET the next day, Friday, August 24, 2018, to review the results. A question and answer session will follow the corporate update.
Based in Toronto, Flow Capital Corp. is a diversified alternative asset investor and advisor, operating two divisions: an investment operation providing revenue-linked capital to emerging growth businesses, and an institutional advisory sales platform providing pension funds, charities and endowment clients with access to leading institutional money managers from around the world. Learn more at www.flowcap.com.
Forfurtherinformation,pleasecontact:
Flow Capital Corp.: Donnacha Rahill Chief FinancialOfficer Tel: (416) 477-2601
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...
TSX VENTURE COMPANIES
BULLETIN V2024-1211
ALPHAMIN RESOURCES CORP. ("AFM")BULLETIN TYPE: Declaration of DividendBULLETIN DATE: April 26, 2024TSX Venture Tier 2 Company
The Issuer has declared the following dividend:
Dividend Amount per Common...
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year ended January 31, 2024. The Company recorded net earnings and comprehensive income attributable to shareholders of the...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
